Optimal interventional treatment for liver cancer:HAIC,TACE or iTACE?

作     者：Naijian Ge Hongbo Wang Chengjian He Xiangdong Wang Jian Huang Yefa Yang Naijian Ge;Hongbo Wang;Chengjian He;Xiangdong Wang;Jian Huang;Yefa Yang

作者机构：Mini-Invasive Intervention CenterThird Affiliated Hospital of Naval Medical University/Shanghai Eastern Hepatobiliary Surgery HospitalShanghai200438China 

出 版 物：《Journal of Interventional Medicine》 (介入医学杂志（英文）)

年 卷 期：2023年第6卷第2期

页      面：59-63页

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Hepatocellular carcinoma Hepatic artery infusion chemotherapy Transcatheter arterial chemoembolization 

摘      要：Primary liver cancer is a common and lethal malignancy in *** arterial chemoembolization(TACE)is globally recognized as the preferred treatment modality for the non-surgical resection of hepatocellular carcinoma(HCC),while transcatheter arterial infusion(TAI)is another effective interventional treatment for *** recent years,hepatic arterial infusion chemotherapy(HAIC)has gained increasing attention as an application-regulated modality for *** to the current debate in the medical community regarding the use of HAIC and TACE for the treatment of HCC,the application of both approaches should be considered at a higher level,with a broader perspective and a more normative ***,we aimed to define the rational combination of liver cancer TAI/HAIC with TACE as infusion transcatheter chemoembolization(iTACE),which suggests that the two interventions are not superior but lead to a mutually beneficial *** this review,we sought to discuss the development,specification,application,challenge and innovation,debate,and union of TAI/HAIC and TACE,and the clinical application and latest research on *** aimed to introduce new concepts of iTACE and expect new breakthroughs in the treatment of liver cancer owing to the combined use of the two major interventional tools.